INKT logo

MiNK Therapeutics (INKT) Company Overview

Profile

Full Name:

MiNK Therapeutics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

October 15, 2021

Indexes:

Not included

Description:

MiNK Therapeutics, also known as INKT, focuses on developing innovative cell therapies for cancer treatment. They use a unique approach to harness the power of immune cells, aiming to improve patient outcomes and provide new options for those with difficult-to-treat cancers.

Events Calendar

Earnings

Next earnings date:

Mar 21, 2025

Recent quarterly earnings:

Nov 14, 2024

Recent annual earnings:

Mar 21, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Jan 28, 2025

Analyst ratings

Recent major analysts updates

Feb 25, 25 HC Wainwright & Co.
Buy
Nov 15, 24 HC Wainwright & Co.
Buy
Nov 15, 24 Baird
Outperform
Oct 9, 24 HC Wainwright & Co.
Buy
Aug 13, 24 HC Wainwright & Co.
Buy
May 14, 24 HC Wainwright & Co.
Buy
Mar 21, 24 HC Wainwright & Co.
Buy
Aug 10, 23 HC Wainwright & Co.
Buy
May 12, 23 HC Wainwright & Co.
Buy
Apr 19, 23 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for MiNK Therapeutics?
  • Does MiNK Therapeutics pay dividends?
  • What sector is MiNK Therapeutics in?
  • What industry is MiNK Therapeutics in?
  • What country is MiNK Therapeutics based in?
  • When did MiNK Therapeutics go public?
  • Is MiNK Therapeutics in the S&P 500?
  • Is MiNK Therapeutics in the NASDAQ 100?
  • Is MiNK Therapeutics in the Dow Jones?
  • When was MiNK Therapeutics's last earnings report?
  • When does MiNK Therapeutics report earnings?
  • Should I buy MiNK Therapeutics stock now?

What is the ticker symbol for MiNK Therapeutics?

The ticker symbol for MiNK Therapeutics is NASDAQ:INKT

Does MiNK Therapeutics pay dividends?

No, MiNK Therapeutics does not pay dividends

What sector is MiNK Therapeutics in?

MiNK Therapeutics is in the Healthcare sector

What industry is MiNK Therapeutics in?

MiNK Therapeutics is in the Biotechnology industry

What country is MiNK Therapeutics based in?

MiNK Therapeutics is headquartered in United States

When did MiNK Therapeutics go public?

MiNK Therapeutics's initial public offering (IPO) was on October 15, 2021

Is MiNK Therapeutics in the S&P 500?

No, MiNK Therapeutics is not included in the S&P 500 index

Is MiNK Therapeutics in the NASDAQ 100?

No, MiNK Therapeutics is not included in the NASDAQ 100 index

Is MiNK Therapeutics in the Dow Jones?

No, MiNK Therapeutics is not included in the Dow Jones index

When was MiNK Therapeutics's last earnings report?

MiNK Therapeutics's most recent earnings report was on Nov 14, 2024

When does MiNK Therapeutics report earnings?

The next expected earnings date for MiNK Therapeutics is Mar 21, 2025

Should I buy MiNK Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions